Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 41 citing articles:

Stimuli-activatable nanomedicine meets cancer theranostics
Haonan Li, Feng Yue, Qiang Luo, et al.
Theranostics (2023) Vol. 13, Iss. 15, pp. 5386-5417
Open Access | Times Cited: 147
A Nanographene‐Porphyrin Hybrid for Near‐Infrared‐Ii Phototheranostics
Hao Zhao, Yu Wang, Qiang Chen, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 22
Recent advances in the design of organic photothermal agents for cancer treatment: A review
Seongman Lee, Suhong Min, Gahyun Kim, et al.
Coordination Chemistry Reviews (2024) Vol. 506, pp. 215719-215719
Closed Access | Times Cited: 20
Gene and Photothermal Combination Therapy: Principle, Materials, and Amplified Anticancer Intervention
Fang Tang, Aixiang Ding, Yao Xu, et al.
Small (2023) Vol. 20, Iss. 6
Closed Access | Times Cited: 34
Two Key Descriptors for Designing Second Near-Infrared Dyes and Experimental Validation
Yi Zeng, Jiamin Qu, Guanghao Wu, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 14, pp. 9888-9896
Closed Access | Times Cited: 15
Mitochondrial‐Targeted CS@KET/P780 Nanoplatform for Site‐Specific Delivery and High‐Efficiency Cancer Immunotherapy in Hepatocellular Carcinoma
Shanshan Liu, Hailong Tian, Hui Ming, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 12
Engineering aggregates of julolidine-substituted aza-BODIPY nanoparticles for NIR-II photothermal therapy
Lulu Cao, Yikun Li, Dongxiang Zhang, et al.
Chinese Chemical Letters (2024) Vol. 35, Iss. 12, pp. 109735-109735
Closed Access | Times Cited: 7
USP18 Antagonizes Pyroptosis by Facilitating Selective Autophagic Degradation of Gasdermin D
Liqiu Wang, Mengqiu Li, Guang‐Yu Lian, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 7
Apoptosis‐Sensitizing Tumor Nanomedicine by Regulating Pyroptosis‐Associated Inflammatory Cell Death
Fangxue Du, Hongxin Zhao, Yangmeihui Song, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 44
Closed Access | Times Cited: 7
Near‐Infrared Light‐Driving Organic Photothermal Agents with an 88.9% Photothermal Conversion Efficiency for Image‐Guided Synergistic Phototherapy
Xilin Zhao, Mengxin Sun, Cao Xiaohan, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 19
Closed Access | Times Cited: 6
Terahertz wave alleviates comorbidity anxiety in pain by reducing the binding capacity of nanostructured glutamate molecules to GluA2
Zihua Song, Yuankun Sun, Pan Liu, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 6
Novel NIR-II 3,5-Julolidinyl aza-BODIPY for Photothermal Therapy of Gliomas Stem Cells by Brain Stereotactic Injection
Lulu Cao, Zhiqiang Cui, Dongxiang Zhang, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 10, pp. 4765-4773
Closed Access | Times Cited: 4
Bilateral Synergistic Effects of Phototherapy‐Based NIR‐II Absorption Photosensitizer for Allergic Rhinitis
Tao Shao, Lu Han, Yang Xie, et al.
Small (2025)
Closed Access
Laser driven 2D heterostructure nanocomposite membranes with bimodal photothermal and photodynamic functions
Congcong Wang, Yu Meng, Cuilu Xi, et al.
Journal of Materiomics (2025), pp. 101050-101050
Open Access
Engineered Cell Membrane Coating Technologies for Biomedical Applications: From Nanoscale to Macroscale
Yongqi An, Cheng Ji, Hao Zhang, et al.
ACS Nano (2025)
Closed Access
BODIPY-Based Photothermal Agent Incorporating Azulene for Enhanced NIR Absorption and Tumor Ablation
Kai Nishimura, Mikiya Kato, Tomoya Fukui, et al.
Molecular Pharmaceutics (2025)
Closed Access
Organic nanoparticles based on aza-boron dipyrromethene derivatives for combined photothermal and photodynamic cancer therapy
Huishuang Zhang, Qilong Sha, Guojing Li, et al.
Materials Today Chemistry (2024) Vol. 37, pp. 102018-102018
Closed Access | Times Cited: 3
A thermoresponsive nanocomposite integrates NIR-II-absorbing small molecule with lonidamine for pyroptosis-promoted synergistic immunotherapy
Pengfei Chen, Chi Zhang, Liuliang He, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Biomimetic celastrol nanocrystals with enhanced efficacy and reduced toxicity for suppressing breast cancer invasion and metastasis
Shuang Du, Kui Wu, Yucheng Guan, et al.
International Journal of Pharmaceutics (2025) Vol. 671, pp. 125221-125221
Closed Access
Albumin-Energized NIR-II Cyanine Dye for Fluorescence/Photoacoustic/Photothermal Multi-Modality Imaging-Guided Tumor Homologous Targeting Photothermal Therapy
Shanshan Jiang, Wanyu Li, Benhao Li, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Development of small-molecule NIR-II photothermal agents for image-guided tumor therapy
Long He, Yi Li, Chonghua Zhang, et al.
Coordination Chemistry Reviews (2025) Vol. 533, pp. 216549-216549
Closed Access
NIR-II absorbing aza-BODIPY with the D-A-A’ framework for PTT/PDT co-therapy
Xin Zhang, Ziyue Xi, Dongxiang Zhang, et al.
Chinese Chemical Letters (2025), pp. 111041-111041
Closed Access
Illuminating oral health: AIEgens for phototheranostics
Jingyuan Chen, Wenhao Yan, Xinyu Wang, et al.
(2025), pp. 100012-100012
Open Access
NIR-II Photosensitizer-Based Nanoparticles Defunctionalizing Mitochondria to Overcome Tumor Self-Defense by Promoting Heat Shock Protein 40
Panpan Li, Jiaxin Zhang, Tao Shao, et al.
ACS Nano (2025)
Closed Access
NIR-II emitting B,O-chelated twisted dye aza-BODIPY for phototherapy
Yaqing Niu, Qinsiyu Ma, Yikun Li, et al.
Dyes and Pigments (2025), pp. 112855-112855
Closed Access
Page 1 - Next Page

Scroll to top